PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rare, mysterious brain malformations in children linked to protein misfolding, study finds

Mutations in a complex that helps proteins fold correctly are tied to developmental disorders that include seizures and intellectual disability, Stanford Medicine-led research has found

2024-11-27
(Press-News.org) In 1992, Judith Frydman, PhD, discovered a molecular complex with an essential purpose in all of our cells: folding proteins correctly.

The complex, a type of “protein chaperone” known as TRiC, helps fold thousands of human proteins: It was later found that about 10% of all our proteins pass through its barrel structure.

All animals have several different kinds of protein chaperones, each with its own job of helping fold proteins in the cell. TRiC binds to newborn proteins and shapes these strings of amino acids into the correct 3D structures, allowing them to carry out their important functions in the cell.

Frydman, the Donald Kennedy Chair in the School of Humanities and Sciences and a professor of biology and genetics, met Ingo Kurth, MD, a pediatrician at the RWTH Aachen University, during a recent sabbatical in Germany, who presented her with an interesting conundrum. Three decades after Frydman’s discovery and many more insights into TRiC’s mechanism later, the pediatrician had found a mutation in one of TRiC’s components in a child with intellectual disability, seizures and brain malformations.

Could the TRiC mutation be responsible for the child’s symptoms? Although dysfunctions in the complex are linked to cancer and Alzheimer’s disease, germline mutations — mutations present in all cells in an organism — in TRiC had never been implicated in a developmental disease. Because proteins must be folded correctly to function correctly and because TRiC is involved in shaping so many proteins, scientists assumed any mutation that altered TRiC’s ability to fold proteins would be lethal.

Frydman and her laboratory team set up a collaboration with the RWTH Aachen University researchers to find out more. Along with collaborators from Washington University School of Medicine in St. Louis, Missouri, the team explored how this patient’s mutation, which is in a gene known as CCT3, affects TRiC function in roundworms, baker’s yeast and zebrafish. Meanwhile, the pediatricians combed through a genetic database of patients with intellectual disabilities and neurodevelopmental defects similar to those of the original patient. They found 21 more cases of patients with alike symptoms, albeit ranging in severity, with mutations in 7 of the 8 components of TRiC. The Frydman lab showed that all the additional 21 mutations impair TRiC function, causally linking TRiC defects to the brain disorders.

A new class of disease The researchers dubbed this new class of neurological diseases “TRiCopathies” and describe their findings in an article published Oct. 31 in Science. The team has since found an additional patient with mutations in the eighth TRiC subunit.

“This opens a whole new way of thinking about the role of chaperones in brain development,” said Frydman, who is one of the senior authors on the study.

All the patients the researchers identified have one healthy copy of the TRiC complex gene in addition to the mutated version. That squares with the chaperone’s importance — two mutated copies of any of these genes would likely be lethal. Although some of the patients also have muscular deficiencies, it’s interesting that the primary effect of these mutations appears to be neurological, Frydman said. That could point to an outsized role for this chaperone in brain development.

Over the years, her lab has developed methods to study the complex in yeast cells as well as isolated in test tubes. Research scientist Piere Rodriguez-Aliaga, PhD, co-first author on the study, made mutations in the yeast versions of TRiC genes that corresponded to the 22 disease-linked human mutations. He found that some of these mutations led to death of the cells but some did not, indicating that different mutations have different effects depending on the location of these mutations within the TRiC complex, which may explain the diversity of symptoms seen in patients.  

Other researchers in the collaboration made similar mutations in roundworms and zebrafish to study how the mutations affected multicellular animals and, in the case of the zebrafish, brain development.

In all three organisms, the researchers found that having only the mutated version CCT3, the TRiC gene, was lethal. In worms and zebrafish, which, like us, have two copies of all their genes, animals with one mutated copy and one healthy copy survived, but the mutated version caused developmental problems. Zebrafish with one mutated CCT3 showed defects in brain development similar to those seen in the human patients, and worms with the mutated gene had problems with movement.

Although it’s not clear which misfolded protein or proteins may be causing the neurological symptoms, the researchers suspect that structural proteins known as actin and tubulin are involved. These proteins are important for cells’ movement and internal stability and are known to be folded by TRiC. Worms carrying TRiC mutations had tiny aggregates of actin not present in healthy animals, a phenomenon that often happens with misfolded proteins. Organelles required for energy called mitochondria, which are key to neuronal function, were also affected.

Frydman and Rodriguez-Aliaga plan to study the mechanism of the disease-linked mutations in more detail by exploring how they affect TRiC’s ability to fold proteins, using methods they’ve established in their lab to study protein folding. They also want to use patient-derived cells they can grow into neurons or brain organoids in the lab to see how the mutations affect human brain cells.

“This work is a nice example of basic science connecting with medicine,” Rodriguez-Aliaga said. “The study would not have been possible without all the years of biochemistry and biophysics done in TRiC since 1992.”

See the paper for other institutions involved in the study as well as funding for the research.

 

# # #

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Newly designed nanomaterial shows promise as antimicrobial agent

Newly designed nanomaterial shows promise as antimicrobial agent
2024-11-27
HOUSTON – (Nov. 27, 2024) – Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective and easy to produce. After almost three years, Rice University scientist Yifan Zhu and colleagues have developed a new HPNC that is effective at killing bacteria in a biofluid under visible light without experiencing light- and moisture-driven degradation common in HPNCs. A new method using two layers of silicon dioxide that Zhu and colleagues developed over years of work was used in experiments with lead-based and bismuth-based HPNCs to test their antimicrobial efficacy and stability in water. ...

Scientists glue two proteins together, driving cancer cells to self-destruct

2024-11-27
Our bodies divest themselves of 60 billion cells every day through a natural process of cell culling and turnover called apoptosis. These cells — mainly blood and gut cells — are all replaced with new ones, but the way our bodies rid themselves of material could have profound implications for cancer therapies in a new approach developed by Stanford Medicine researchers. They aim to use this natural method of cell death to trick cancer cells into disposing of themselves. Their method accomplishes this by artificially bringing together two proteins in such a way that the new compound switches on a set of cell death genes, ultimately driving tumor cells to turn on themselves. ...

Intervention improves the healthcare response to domestic violence in low- and middle-income countries

Intervention improves the healthcare response to domestic violence in low- and middle-income countries
2024-11-27
Culturally appropriate women-centred interventions can help healthcare systems respond to domestic violence, research has found. HERA (Healthcare Responding to Violence and Abuse) has been co-developing and evaluating a domestic violence and abuse healthcare intervention in low- and middle-income countries for the past five years. This National Institute for Health and Care Research (NIHR) Global Research Group will report their findings, and publish a PolicyBristol report, at a conference in London today ...

State-wide center for quantum science: Karlsruhe Institute of Technology joins IQST as a new partner

State-wide center for quantum science: Karlsruhe Institute of Technology joins IQST as a new partner
2024-11-27
The mission of IQST is to further our understanding of nature and develop innovative technologies based on quantum science by leveraging synergies between the natural sciences, engineering, and life sciences. "Many KIT scientists already successfully support IQST with their expertise as Fellows. All the more I am pleased that the Karlsruhe Institute of Technology is now joining our interdisciplinary centre as an institution," says IQST Director Prof. Stefanie Barz. "This will strengthen networking within the academic quantum community in Baden-Württemberg," emphasizes ...

Cellular traffic congestion in chronic diseases suggests new therapeutic targets

Cellular traffic congestion in chronic diseases suggests new therapeutic targets
2024-11-27
***Embargoed until November 27 at 11 AM EST*** Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of disease burden and deaths around the globe, are physically and economically taxing, and the number of people with such diseases is growing. Treating chronic disease has proven difficult because there is not one simple cause, like a single gene mutation, that a treatment could target. At least, that’s how it has appeared to scientists. However, research from Whitehead Institute Member Richard Young and colleagues, published in the journal ...

Cervical cancer mortality among US women younger than age 25

2024-11-27
About The Study: This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This cohort of women is the first to be widely protected against cervical cancer by human papillomavirus (HPV) vaccines. The findings from this study in the context of other published research suggest that HPV vaccination affected the sequential decline in HPV infection prevalence, cervical cancer incidence, and cervical cancer mortality.  Corresponding ...

Fossil dung reveals clues to dinosaur success story

Fossil dung reveals clues to dinosaur success story
2024-11-27
In an international collaboration, researchers at Uppsala University have been able to identify undigested food remains, plants and prey in the fossilised faeces of dinosaurs. These analyses of hundreds of samples provide clues about the role dinosaurs played in the ecosystem around 200 million years ago. The findings have been published in the journal Nature. “Piecing together ‘who ate whom’ in the past is true detective work,” says Martin Qvarnström, researcher at the Department of Organismal Biology and lead author of the study. “Being able to examine what animals ate and how they interacted with their environment helps us understand what enabled ...

New research points way to more reliable brain studies

2024-11-27
Brain-wide association studies, which use magnetic resonance imaging to identify relationships between brain structure or function and human behavior or health, have faced criticism for producing results that often cannot be replicated by other researchers.  A new study published in Nature demonstrates that careful attention to study design can substantially improve the reliability of this type of research. For the study, Kaidi Kang, a biostatistics PhD student, Simon Vandekar, PhD, associate professor of Biostatistics, and colleagues analyzed data from more than 77,000 brain scans across 63 studies.  The ...

‘Alzheimer’s in dish’ model shows promise for accelerating drug discovery

2024-11-27
A decade ago, researchers introduced a new model for studying Alzheimer’s disease. Known as “Alzheimer’s in a dish,” the model uses cultures of mature brain cells suspended in a gel to recapitulate what takes place in the human brain over 10 to 13 years in just six weeks. But does the model truly produce the same changes that take place in patients? In a new study, researchers from Mass General Brigham, in collaboration with colleagues at Beth Israel Deaconess Medical Center (BIDMC), created an algorithm to assess, in an unbiased manner, how well models of Alzheimer’s disease ...

Ultraprocessed food intake and psoriasis

2024-11-27
About The Study: The results of this study showed an association between high ultraprocessed food intake and active psoriasis status. After adjustments for age, body mass index (BMI), alcohol intake, and comorbidities, the results remained significant, suggesting that ultraprocessed food intake has a proinflammatory action separate from high BMI. Corresponding Author: To contact the corresponding author, Emilie Sbidian, MD, PhD, email emilie.sbidian@aphp.fr. To access the embargoed study: ...

LAST 30 PRESS RELEASES:

Wrong trees in the wrong place can make cities hotter at night, study reveals

New gene therapy reverses heart failure in large animal model

Young children less likely than adults to see discrimination as harmful

Tiny poops in the ocean may help solve the carbon problem

Study offers insight into chloroplast evolution

Advancing the synthesis of two-dimensional gold monolayers

Human disruption is driving ‘winner’ and ‘loser’ tree species shifts across Brazilian forests

A novel heme-model compound that treats lethal gas poisoning

Shape-changing device helps visually impaired people perform location task as well as sighted people - EMBARGO: Tuesday 10 December (10:00 UK time)

AI predicts that most of the world will see temperatures rise to 3°C much faster than previously expected

Second round of FRONTIERS Science Journalism Residency Program awards grants to ten journalists

The inequity of wildfire rescue resources in California

Aerosol pollutants from cooking may last longer in the atmosphere – new study

Breakthrough in the precision engineering of four-stranded β-sheets

Family income predicts adult problems more than neighborhood poverty

Leading stress expert Ron de Kloet on hormone's dual nature: From protection to harm

Almost half of young vapers are able to stop with quitline help

After a divisive election, most U.S. adults ready to avoid politics this holiday

Food insecurity in LA County remains well above national average, despite slight decline

People with a positive attitude are built differently

AML, sickle cell disease research among highlights of UC ASH abstracts

Dozens of presentations advance multiple myeloma research at the 2024 American Society for Hematology (ASH) meeting

ASH 2024: Study shows that genetic mutations accumulate in smokers with myelodysplastic syndromes and worsen outcomes

Nature inspires self-assembling helical polymer

Could US-style summer holiday programs boost Aussie kids’ health?

Towards safer, higher performance batteries through network topology optimization

ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias

Toxoplasma gondii parasite uses unconventional method to make proteins for evasion of drug treatment

US e-scooter/e-bike injuries have tripled since 2019, fuelled by alcohol/substance use

Cost stops 1 in 6 US adults with asthma from taking meds as prescribed, study suggests

[Press-News.org] Rare, mysterious brain malformations in children linked to protein misfolding, study finds
Mutations in a complex that helps proteins fold correctly are tied to developmental disorders that include seizures and intellectual disability, Stanford Medicine-led research has found